Your browser doesn't support javascript.
loading
Risk Factors Associated with Mortality in Acinetobacter baumannii Infections: Results of a Prospective Cohort Study in a Tertiary Public Hospital in Guayaquil, Ecuador.
Abarca-Coloma, Luz; Puga-Tejada, Miguel; Nuñez-Quezada, Tamara; Gómez-Cruz, Otilia; Mawyin-Muñoz, Carlos; Barungi, Shivan; Perán, Macarena.
Afiliação
  • Abarca-Coloma L; Critical Care Unit Hospital Teodoro Maldonado Carbo, Catholic University Santiago of Guayaquil, Guayaquil 090203, Ecuador.
  • Puga-Tejada M; Instituto Ecuatoriano de Enfermedades Digestivas (IECED), Guayaquil 090505, Ecuador.
  • Nuñez-Quezada T; Department of Medical Microbiology Hospital Teodoro Maldonado Carbo, Catholic University Santiago of Guayaquil, Guayaquil 090203, Ecuador.
  • Gómez-Cruz O; Infection Prevention and Control Program, Hospital Teodoro Maldonado Carbo, Guayaquil 090203, Ecuador.
  • Mawyin-Muñoz C; Critical Care Unit Hospital Teodoro Maldonado Carbo, Catholic University Santiago of Guayaquil, Guayaquil 090203, Ecuador.
  • Barungi S; Department of Health Sciences, University of Jaén, 23071 Jaén, Spain.
  • Perán M; Department of Health Sciences, University of Jaén, 23071 Jaén, Spain.
Antibiotics (Basel) ; 13(3)2024 Feb 23.
Article em En | MEDLINE | ID: mdl-38534648
ABSTRACT
Antibiotic overuse and the resulting antimicrobial resistance pose significant global public health challenges, providing an avenue for opportunistic pathogens like Acinetobacter baumannii to thrive. This study will report the trends of Acinetobacter baumannii antimicrobial resistance patterns at the Hospital Teodoro Maldonado Carbo, Ecuador. An observational, analytical, longitudinal, and prospective study was conducted involving patients diagnosed with hospital-acquired infections. Antimicrobial susceptibility testing was performed, followed by molecular analysis of carbapenemase genes in Acinetobacter baumannii isolates. We included 180 patients aged from 16 to 93 years. The hospital mortality rate was 63/180 (35%). Invasive mechanical ventilation (IMV) was indicated in 91/180 patients (50.4%). The overall survival (OS) rate in patients on IMV was 49.5% (45/91), with a median survival of 65 days. The OS rate in patients not on IMV was 80.9% (72/89), with a median survival of 106 days (HR 2.094; 95% CI 1.174-3.737; p = 0.012). From multivariate analysis, we conclude that ventilator-associated pneumonia is the most related factor to OS.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: America do sul / Ecuador Idioma: En Revista: Antibiotics (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Equador País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: America do sul / Ecuador Idioma: En Revista: Antibiotics (Basel) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Equador País de publicação: Suíça